-
4-amino-1-[(2S,4S,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydro(2-13C,1,3-15N2)pyrimidin-2-one hydrochloride
-
ChemBase ID:
168052
-
Molecular Formular:
C9H12ClF2N3O4
-
Molecular Mass:
302.63855903
-
Monoisotopic Mass:
302.04586462
-
SMILES and InChIs
SMILES:
Cl.[C@H]1(C([C@H](O[C@@H]1CO)[15n]1[13c](=O)[15n]c(cc1)N)(F)F)O
Canonical SMILES:
OC[C@H]1O[C@@H](C([C@H]1O)(F)F)[15n]1ccc([15n][13c]1=O)N.Cl
InChI:
InChI=1S/C9H11F2N3O4.ClH/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17;/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17);1H/t4-,6+,7+;/m1./s1/i8+1,13+1,14+1;
InChIKey:
OKKDEIYWILRZIA-RQCSKJJRSA-N
-
Cite this record
CBID:168052 http://www.chembase.cn/molecule-168052.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
|
IUPAC name
|
|
4-amino-1-[(2S,4S,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydro(2-13C,1,3-15N2)pyrimidin-2-one hydrochloride
|
|
|
|
|
IUPAC Traditional name
|
|
4-amino-1-[(2S,4S,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl](2-13C,1,3-15N2)pyrimidin-2-one hydrochloride
|
|
|
|
|
Synonyms
|
|
4-Amino-1-(2-deoxy-2,2-difluoro-α-D-erythro-pentofuranosyl)-2(1H)-pyrimidinone Hydrochloride-13C,15N2
|
|
1'-Epi Gemcitabine-13C,15N2 Hydrochloride
|
|
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
|
Data Source
|
Data ID
|
Price
|
|
TRC
|
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
|
Acid pKa
|
11.51707
|
H Acceptors
|
6
|
H Donor
|
3
|
LogD (pH = 5.5)
|
-1.4665402
|
LogD (pH = 7.4)
|
-1.4665728
|
Log P
|
-1.4665396
|
Molar Refractivity
|
53.2503 cm3
|
Polarizability
|
20.563793 Å3
|
Polar Surface Area
|
108.38 Å2
|
Rotatable Bonds
|
2
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
TRC
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • Hertel, L.W., et al.: Cancer Res., 50, 4417 (1990)
- • Abbruzzese, J.L., et al.: J. Clin. Oncol., 9, 491 (1990)
- • Ruiz, V.W.T., et al.: Biochem. Pharmacol., 46, 762 (1990)
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent